FDA to Host Public Conference on Measuring Liver Injury from Drugs in Clinical Trials

Summary

The FDA is hosting a public conference to discuss and debate how to measure, evaluate, and respond to liver injury and dysfunction caused by drugs used in clinical trials, in collaboration with the Critical Path Institute.